#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The coupling of the M2 muscarinic receptor to its G protein is voltage dependent


Authors: Yair Ben-Chaim aff001;  Chava Broide aff002;  Hanna Parnas aff002
Authors place of work: Department of Natural and Life Sciences, The Open University of Israel, Ra'anana, Israel aff001;  Department of Neurobiology, Institute of Life Sciences, The Hebrew University, Jerusalem, Israel aff002
Published in the journal: PLoS ONE 14(10)
Category: Research Article
doi: https://doi.org/10.1371/journal.pone.0224367

Summary

G protein coupled receptors (GPCRs) participate in the majority of signal transduction processes in the body. Specifically, the binding of an external agonist promotes coupling of the GPCR to its G protein and this, in turn, induces downstream signaling. Recently, it was shown that agonist binding to the M2 muscarinic receptor (M2R) and to other GPCRs is voltage dependent. Here we examine, whether the coupling of the M2R to its G protein is also voltage-dependent. We first show, in Xenopus oocytes, that the activity of the M2R in the absence of agonist (constitutive activity) can be used to report the coupling. We then show that the coupling is, by itself, voltage dependent. This novel finding is of physiological importance, as it shows that the actual signal transduction, whose first step is the coupling of the GPCR to its cognate G protein, is voltage dependent.

Keywords:

signal transduction – Membrane potential – Depolarization – Xenopus oocytes – Oocytes – G protein coupled receptors – Atropine – G-protein signaling

Introduction

Binding of agonists to GPCRs promotes coupling of the latter to their G protein and this, in turn, induces downstream signaling [1]. The binding of agonists to GPCRs [27], and the efficacy of agonists [810], was shown to be voltage dependent We provided experimental evidence indicating that the coupling of the M2R to its G protein plays a role in controlling the voltage dependence of agonist binding to the M2R [2,3,11]. Based on these results we hypothesized that the coupling itself may be voltage dependent [11]. To test this hypothesis, it is necessary to examine the coupling itself.

The M2R, as well as other GPCRs, induces downstream signaling even in the absence of agonist. This activity, termed "constitutive activity", was interpreted to be a result of a spontaneous coupling of the receptor to its G protein [1215]. Therefore, constitutive activity measurements may be used as a new experimental paradigm to examine the coupling itself.

To measure the constitutive activity we used, as in our earlier studies [3,11], Xenopus oocytes as an expression system and M2R-activated GIRK (G protein-activated inward rectifying K+ channel) currents as a measure for M2R signaling.

Here we show that the M2R exhibits constitutive activity. We further show that this constitutive activity reflects the coupling of the M2R to its cognate G protein. We finally show that the coupling is voltage dependent.

Materials and methods

Frogs were used according to guidelines of the Hebrew University in Jerusalem and studies were approved by the Institutional Animal Care and Use Committee. Xenopus oocytes were prepared, injected, and maintained as previously described [16,17]. Constructs were linearized and transcribed as previously described [18]. The triple mutant was constructed using QuikChange site-directed mutagenesis kit (Agilent technologies, CA, USA).

GIRK current measurements

Currents were recorded using the standard two-electrode voltage-clamp technique (Axoclamp 2B amplifier; Axon Instruments). pCLAMP8 software (Axon Instruments) was used for data acquisition and analysis. G protein-activated inwardly rectifying K+ (GIRK) currents were measured as described [3]. Briefly, oocytes were injected with 2 ng of the M2R (wt or the triple mutant), 200 pg of each of the two subunits of the GIRK channel (GIRK1 and GIRK2), and with 1 ng of the Gαi3 subunit. The oocyte was clamped to the desired holding potential in the ND96 solution (96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, pH adjusted to 7.4 with NaOH). K+ currents were developed upon replacement of the ND96 by a 24 mM K+ solution (72 mM NaCl, 24 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, pH adjusted to 7.4 with KOH).

The expression of the M2R was evaluated, as described before [2], from measurements of [3H]Quinuclidinyl benzilate ([3H]QNB; specific activity 47.4 Ci/mmol, PerkinElmer, Waltham, MA) binding to intact oocytes. Expression level was ~18 fmol per oocyte in all experiments where either wt M2R or the mutant receptors were expressed.

For the PTX experiments, PTX protomer A (15 ng/oocyte; list biological laboratories, Campbell, CA) was injected to oocytes 12–20 hours before the experiment. The uncoupling of G-protein from the m2R following PTX treatment was verified before each experiment by two electrode voltage clamp measurements of acetylcholine (Sigma-Aldrich, Rehovot, Israel) induced GIRK currents [3].

Statistical evaluation

Significance was checked by unpaired Student’s t test.

Results and discussion

The M2R exhibits constitutive activity

To investigate whether the M2R exhibits constitutive activity we used the muscarinic inverse agonist atropine. It was shown that constitutive activity in muscarinic receptors can be blocked by atropine [12,13]. Therefore, it is expected that if the M2R does exhibit constitutive activity, atropine will block it.

To examine whether this expectation is met we conducted the following experiment (Fig 1A, top). An oocyte expressing the M2R and the GIRK channel was voltage clamped to -80 mV in a low K+ solution (ND96, see Materials and Methods). Then, the solution was changed to high K+ (24 mM) and K+ currents (IK) were developed. The magnitude of IK is calculated by subtracting the current amplitude in ND96, representing the background, GIRK-independent current, from the current amplitude in 24 mM K+.

Measurement of constitutive activity in the M2R, using the atropine procedure.
Fig. 1. Measurement of constitutive activity in the M2R, using the atropine procedure.
(A) The effect of 100 μM atropine on oocytes expressing both the M2R and GIRK channel. (top) A representative recording from one oocyte. (bottom) Collected data from 26 oocytes. Each two data points connected with a line represent IKS (black) and IKB (red), from one oocyte. The averages of IKS and IKB are denoted by the horizontal lines. The ratio IKS/ IKB is given in the box. (B) The effect of 100 μM atropine on oocytes expressing only the GIRK channel. (top) A representative recording from one oocyte. (bottom) Data from 5 oocytes. Each two data points connected with a line represent IK from one oocyte before (black) and after (red) the addition of atropine. The averages of IK before and after the addition of atropine are denoted by the horizontal lines.

Because the oocytes express both the M2R and the GIRK channel, the IK that had developed is IKS, where IKS = IKB + IKR, where IKB is the basal IK produced by activation of the GIRK channel by the basal free Gβγ present in the oocyte [19] and IKR is the additional IK that is presumably produced by the constitutive activity of the M2R. Once IKS reached a steady state, atropine (100 μM) was applied (Fig 1A, see arrow) and IKS declined and reached a new steady state. Because 100 μM atropine completely block IKR (see S1 Fig), this new steady state reflects IKB.

The experiment described above was repeated in 26 oocytes, and the results are depicted in Fig 1A, bottom. For each oocyte the amplitudes of IKS (black circles) and IKB (red circles) are shown, and the average of each is depicted by a horizontal line. In 24 of the 26 oocytes, the addition of atropine reduced IKS.

To check whether atropine affects the GIRK channel itself, we repeated the experiment of Fig 1A in oocytes expressing only the GIRK channel (Fig 1B). It is seen that in these oocytes the addition of atropine does not affect IK, indicating that atropine does not have an effect on the GIRK channel itself.

The results seen in Fig 1A, where IKS declined following the addition of atropine in oocytes expressing the M2R, support the conclusion that the M2R exhibits constitutive activity (IKR) and that atropine indeed blocks it.

Another way, independent of the use of atropine, to examine whether the M2R exhibits constitutive activity is to compare IK in two separate groups of oocytes: oocytes expressing both the GIRK channel and the M2R (group 1, Fig 2A) and oocytes expressing only the GIRK channel (group 2, Fig 2B). In group 1, IK corresponds to IKS, i.e. the sum of IKB and IKR, whereas in group 2, IK corresponds only to IKB. We expect that if the M2R exhibits constitutive activity, then the amplitude of IK in steady state will be higher in group 1 than in group 2.

Measurement of constitutive activity in the M2R, using two groups of oocytes.
Fig. 2. Measurement of constitutive activity in the M2R, using two groups of oocytes.
(A) group 1: oocytes expressing both the M2R and the GIRK channel. (top) Representative recording. (bottom) Collected data from 61 oocytes. Here and in B, each data point depicts IK measured from one oocyte, and the average IK is denoted by the horizontal line. (B) group 2: oocytes expressing only the GIRK channel. (top) Representative recording. (bottom) Collected data from 61 oocytes. The ratio IKS/ IKB is given in the box.

To test whether the above expectation is met, oocytes from each group were voltage clamped to -80 mV, and IK was measured, as described in Fig 1A. Fig 2A top and 2B top show examples of recordings from each group of oocytes. It is seen, that as expected, the amplitude of IK in steady state is higher in group 1 than in group 2. Such recordings were repeated in 61 oocytes from each group and the cumulative results are seen in Fig 2A bottom and 2B bottom, where each circle represents one oocyte and the average is depicted by a horizontal line. It is seen that, as expected, the average IK in group 1, which corresponds to IKS, is higher than the average IK in group 2, which corresponds solely to IKB (807±53 nA and 667±46 nA, respectively; the difference between the two groups is statistically significant, p<0.05).

The results in Fig 2 further support the conclusion that the M2R exhibits constitutive activity.

In both types of experiments, the constitutive activity, IKR, could not be measured directly, but rather as a constituent of IKS. We are interested, however, in measuring IKR quantitatively. This can be achieved by measuring the ratio IKS/ IKB (see S1 Appendix). This ratio equals 1+ IKR/ IKB. Hence, it will be 1 when IKR = 0 and it will be greater than 1 when constitutive activity takes place, in proportion to the extent of the constitutive activity.

In the experiment where atropine was used (Fig 1), the ratio between the average IKS (Fig 1A bottom, black horizontal line) and the average IKB (Fig 1A bottom, red horizontal line) was found to be 1.29 (Fig 1A, box). In the experiment shown in Fig 2, the average IKS is extracted from oocytes of group 1 (Fig 2A) while the average IKB is extracted from oocytes of group 2 (Fig 2B). This ratio was found to be 1.21 (Fig 2, box).

The resemblance in the values of the ratios obtained from the two types of experiments (1.29 in Fig 1A and 1.21 in Fig 2) implies that both methods are adequate for measuring and defining the extent of the constitutive activity.

The constitutive activity of the M2R reflects its coupling to its G protein

So far, we have shown (Figs 1 and 2) that the M2R exhibits constitutive activity. We now ask whether this constitutive activity (IKR) indeed reflects the coupling of the M2R to its G protein. To answer this question, we used pertussis toxin (PTX), which is known to uncouple Go/i -coupled receptors, such as the M2R, from their G proteins. We expect that if the constitutive activity, IKR, reflects the coupling of the M2R to its G protein, then PTX will reduce it or even completely abolish it. To assess this expectation, we measured, using the atropine procedure, IK in PTX-treated oocytes and compared it to IK in oocytes not treated with PTX. We expect that in contrast to the effect of atropine in the control, PTX-untreated oocytes (Fig 1A, shown for comparison also as dashed line in Fig 3 top), atropine will have no effect in the PTX-treated oocytes. This is because in the PTX untreated oocytes IK before the addition of atropine, IKS, is the sum of IKB+IKR. However, if PTX indeed abolishes IKR, then in the PTX-treated oocytes, IK prior to the addition of atropine will reflect only IKB. Due to the same reason, IK before the addition of atropine is expected to be higher in the PTX untreated oocytes than in the PTX treated ones.

Constitutive activity in PTX treated oocytes.
Fig. 3. Constitutive activity in PTX treated oocytes.
(top) Representative recording from a PTX-treated oocyte (solid line). Recording from control, PTX-untreated, oocyte is shown for comparison as dashed line. The arrows indicate the addition of atropine. (bottom) Collected data from 20 PTX-treated oocytes. Each two data points connected with a line represent IK from one oocyte, before (black) and after (red) the addition of atropine. The averages of IK before and after the addition of atropine are denoted by the horizontal solid lines. The averages of IKS and IKB from control, PTX-untreated, oocytes are shown for comparison as horizontal dashed lines. The ratio IKS/ IKB from PTX-treated oocytes, is given in the box.

Fig 3 shows that the expectations were met. Specifically, in contrast to PTX untreated oocytes (Fig 3 top, dashed line), in PTX-treated oocytes, atropine had no effect on IK (Fig 3 top, solid line), compatible with the conclusion that in these oocytes constitutive activity did not take place. Furthermore, due to the same reason, IK prior to the addition of atropine was lower in PTX-treated oocytes (Fig 3 top, solid line) than in PTX untreated oocytes (Fig 3 top, dashed line).

The experiment described above was repeated in 20 PTX-treated oocytes. It is seen (Fig 3 bottom), that in all 20 oocytes IK after the addition of atropine (red circles) was the same as IK prior to the addition of atropine (black circles), implying that atropine had no effect on IK. Corollary, the average IK prior to the addition of atropine was lower in PTX-treated oocytes (764±134 pA, Fig 3 bottom, horizontal solid line) than in PTX untreated oocytes (1041±112 pA, Fig 3 bottom, horizontal dashed line).

To quantify the effect of PTX on the constitutive activity, we measured the ratio IKS/IKB in PTX-treated oocytes. This ratio was found to be 1.01 (Fig 3, box), in comparison to the ratio of 1.29 in PTX-untreated oocytes (Fig 1A box).

The results in Fig 3 are compatible with the conclusion that the constitutive activity reflects the coupling of the M2R to its G protein (IKR). In the following, therefore, we will use "constitutive activity" and "coupling" interchangeably.

The coupling between the M2R and its G protein is voltage dependent

We now wish to test our hypothesis that the coupling of the M2R to its G protein is voltage dependent. We recall, that the GIRK channel is by itself voltage dependent [19]. Thus, to tease apart the putative voltage dependence of the coupling from the voltage dependence of the GIRK channel, we compared IK in two groups of oocytes. (1) Oocytes expressing the M2R and the GIRK channel. In these oocytes, IK corresponds to the sum of IKB and IKR (IKS), and their voltage dependence reflects both the voltage dependence of the GIRK channel and the putative voltage dependence of IKR. (2) Oocytes expressing only the GIRK channel. In these oocytes, IK corresponds only to IKB and its voltage dependence reflects the voltage dependence of the GIRK channel per se.

Thus, we measured IK in the two groups of oocytes at various holding potentials ranging from -120 mV to +40 mV at 20 mV increments (Fig 4A). The magnitude of IK at each holding potential was evaluated by subtracting the current amplitude in ND96 from that in 24 mM K+ at the same holding potential. The experiment was repeated in 69 oocytes from each group. Fig 4B shows IKS)black) and IKB (red) at each holding potential. It is seen that at hyperpolarized potentials, the average IKS (IKB+IKR) is higher than the average IKB and this difference becomes smaller the higher the depolarization is.

The voltage dependence of the constitutive activity of the M2R.
Fig. 4. The voltage dependence of the constitutive activity of the M2R.
(A) The experimental protocol (upper part) and the IK produced at each holding potential (lower part). IK was calculated by subtracting the current amplitude in ND96 from that in 24 mM K+ in the same holding potential. An example of recording in one holding potential (-80 mV) is shown in green. (B) IKS (black) and IKB (red) measured at various holding potentials. Each data point represents mean ±SEM from 69 oocytes. (C) The voltage dependence of the ratio IKS/IKB.

The results in Fig 4B are compatible with the conclusion that the coupling (IKR) is voltage dependent.

In order to quantify IKR and its putative voltage dependence, we measured the ratio between the average IKS (from oocytes expressing both the M2R and the GIRK channel) and the average IKB (from oocytes expressing only the GIRK channel) at each holding potential. We expect that if IKR is voltage independent, then the ratio will also be voltage independent. On the other hand, if IKR is voltage dependent then the ratio will also be voltage dependent; it will increase if IKR increases at higher membrane potentials and decrease if IKR declines at higher membrane potentials. The results are depicted in Fig 4C and show that the ratio IKS/IKB declines at more positive membrane potentials, supporting the conclusion that the coupling of the M2R to its G protein is voltage dependent. Moreover, the coupling is stronger at hyperpolarization than under depolarization.

The same voltage sensor controls the voltage dependence of both the agonist binding and the coupling

We next ask what controls the voltage dependence of the coupling of the M2R to its G protein.

We had shown that the voltage dependence of binding of acetylcholine (ACh) to the M2R is controlled by a voltage sensor, composed of three tyrosine residues (Tyr104, Tyr403, Tyr426), that is situated in the agonist binding site [18]. We expect that if this voltage sensor controls also the coupling, then the agonist binding and the coupling will show similar voltage dependence. Furthermore, disrupting the voltage sensor will affect similarly both the agonist binding and the coupling.

Fig 5 shows that this is indeed the case. As seen, in wt M2R both the agonist binding (Fig 5A, taken from [18]) and the coupling (Fig 4B, shown for comparison also in Fig 5B) decline at more positive membrane potentials.

Voltage dependence of the binding affinity and the constitutive activity of the wt M2R and the triple mutant.
Fig. 5. Voltage dependence of the binding affinity and the constitutive activity of the wt M2R and the triple mutant.
(A) Dose-response curves obtained from several experiments at -80 mV (black circles) and at +40 mV (red circles) using various concentrations of ACh from wt M2R. Each data point represents the mean ± SEM, n = 5–8; taken from [18]. (B) IKS (black) and IKB (red) measured at various holding potentials from wt M2R; taken from Fig 4B. (C) Dose-response curves from the triple mutant at -80 mV (black circles) and at +40 mV (red circles). Each data point represents the mean ± SEM, n = 6–8. (D) IKS (black circles) and IKB (red circles) measured at various holding potentials. Each data point represents mean ±SEM from 21 oocytes.

We next examined whether disrupting the voltage sensor will have similar effects on the voltage dependence of both the agonist binding and the coupling. To do so we compared the voltage dependence of the agonist binding to the voltage dependence of the coupling in a mutant where the three tyrosine residues of the voltage sensor were replaced by alanine, denoted the triple mutant [18]. Binding of ACh to the triple mutant was measured as described before [3,18]. Specifically, dose-response curves were measured at two holding potentials, -80 mV and +40 mV, using ACh-induced GIRK currents as a measure for ACh binding. As before, to enable comparison between different holding potentials, the response to each concentration of ACh was normalized to the maximal response evoked by ACh at the same holding potential. Fig 5C shows that in contrast to the case of wt M2R, where the binding affinity was voltage dependent [3], in the triple mutant the voltage dependence was abolished; the binding affinity at hyperpolarization was as low as under depolarization. To examine the effect of the triple mutant on the voltage dependence of the coupling we repeated the experiment described in Fig 4A using oocytes expressing the triple mutant. Fig 5D shows that in contrast to the case in the wt, in the triple mutant the voltage dependence of the coupling disappeared; the coupling at hyperpolarization was as low as under depolarization.

The results seen in Fig 5 support the conclusion that the same voltage sensor controls the voltage dependence of both the agonist binding and the coupling.

We showed here, for the first time, that the coupling of a prototypical GPCR, the M2R, to its cognate G protein is voltage dependent. This conclusion is based on the observation that the constitutive activity of the M2R, which we showed to reflect the coupling, is voltage dependent.

GPCRs mediate most signal transduction processes. Specifically, the binding of an external agonist promotes coupling of the GPCR to its cognate G protein and this, in turn, induces downstream signaling.

In recent years, it was shown that GPCRs are voltage sensitive; for several GPCRs it was shown that their binding affinity is voltage dependent [3,7,11,20].

Here, we make a step forward and show that in addition to the binding of agonist, also the actual execution of signal transduction, which is initiated by coupling of the GPCR to its G protein, is voltage dependent. This finding is of utmost physiological importance as it implies that voltage actually controls signal transduction.

Supporting information

S1 Appendix [docx]

S1 Fig [docx]
Determining the atropine concentration that produces maximal block of the constitutive activity.


Zdroje

1. Gether U. Uncovering molecular mechanisms involved in activation of G protein- coupled receptors. Endocr Rev. 2000;21: 90–113. doi: 10.1210/edrv.21.1.0390 10696571

2. Ben-Chaim Y, Chanda B, Dascal N, Bezanilla F, Parnas I, Parnas H. Movement of “gating charge” is coupled to ligand binding in a G-protein-coupled receptor. Nature. 2006;444: 106–109. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17065983 doi: 10.1038/nature05259 17065983

3. Ben-Chaim Y, Tour O, Dascal N, Parnas I, Parnas H. The M2 muscarinic G-protein-coupled receptor is voltage-sensitive. J Biol Chem. 2003;278: 22482–22491. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12684524 doi: 10.1074/jbc.M301146200 12684524

4. Ohana L, Barchad O, Parnas I, Parnas H. The metabotropic glutamate G-protein-coupled receptors mGluR3 and mGluR1a are voltage sensitive. J Biol Chem. 2006. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16760467

5. Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Århem P. Voltage-dependence of the human dopamine D2 receptor. Synapse. 2008;62: 476–480. doi: 10.1002/syn.20509 18361445

6. Rinne A, Birk A, Bünemann M. Voltage regulates adrenergic receptor function. Proc Natl Acad Sci. 2013;110: 1536 LP– 1541. Available: http://www.pnas.org/content/110/4/1536.abstract

7. Mahaut-Smith MP, Martinez-Pinna J, Gurung IS. A role for membrane potential in regulating GPCRs? Trends Pharmacol Sci. 2008;29: 421–429. Available: http://www.sciencedirect.com/science/article/B6T1K-4SYN427-1/2/5c263ff651569ad5af51e20c1f992f34 doi: 10.1016/j.tips.2008.05.007 18621424

8. Navarro-Polanco RA, Galindo EGM, Ferrer-Villada T, Arias M, Rigby JR, Sánchez-Chapula JA, et al. Conformational changes in the M2 muscarinic receptor induced by membrane voltage and agonist binding. J Physiol. 2011;589: 1741–1753. doi: 10.1113/jphysiol.2010.204107 21282291

9. Birk A, Rinne A, Bünemann M. Membrane Potential Controls the Efficacy of Catecholamine-induced β1-Adrenoceptor Activity. J Biol Chem. 2015/09/25. 2015;290: 27311–27320. doi: 10.1074/jbc.M115.665000 26408198

10. Sahlholm K, Barchad-Avitzur O, Marcellino D, Gómez-Soler M M, Fuxe K, Ciruela F, et al. Agonist-specific voltage sensitivity at the dopamine D2S receptor- Molecular determinants and relevance to therapeutic ligands. Neuropharmacology. 2011;61: 937–949. Available: http://www.sciencedirect.com/science/article/pii/S0028390811002668 doi: 10.1016/j.neuropharm.2011.06.022 21752340

11. Ben Chaim Y, Bochnik S, Parnas I, Parnas H. Voltage Affects the Dissociation Rate Constant of the m2 Muscarinic Receptor. PLoS One. 2013;8: e74354. Available: doi: 10.1371/journal.pone.0074354 24019965

12. Nelson CP. Constitutive Activity and Inverse Agonism at the M2 Muscarinic Acetylcholine Receptor. J Pharmacol Exp Ther. 2005;316: 279–288. doi: 10.1124/jpet.105.094383 16188951

13. Jan J, Lucie B, E. E-FE, Stanislav T. Constitutive activity of the M1–M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 2000;377: 275–279. doi: 10.1016/0014-5793(95)01360-1

14. Spalding TA, Burstein ES. Constitutive Activity of Muscarinic Acetylcholine Receptors. J Recept Signal Transduct. 2006;26: 61–85. doi: 10.1080/10799890600567349 16595339

15. Lefkowitz RJ, Cotecchia S, Samama P, Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci. 1993;14: 303–307. doi: 10.1016/0165-6147(93)90048-O 8249148

16. Peleg S, Varon D, Ivanina T, Dessauer CW, Dascal N. G(alpha)(i) controls the gating of the G protein-activated K(+) channel, GIRK. Neuron. 2002;33: 87–99. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11779482 doi: 10.1016/s0896-6273(01)00567-0 11779482

17. Vorobiov D, Bera AK, Keren-Raifman T, Barzilai R, Dascal N. Coupling of the muscarinic m2 receptor to G protein-activated K(+) channels via Galpha(z) and a receptor-Galpha(z) fusion protein. Fusion between the receptor and Galpha(z) eliminates catalytic (collision) coupling. J Biol Chem. 2000;275: 4166–4170. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10660578 doi: 10.1074/jbc.275.6.4166 10660578

18. Barchad-Avitzur O, Priest MF, Dekel N, Bezanilla F, Parnas H, Ben-Chaim Y. A Novel Voltage Sensor in the Orthosteric Binding Site of the M2 Muscarinic Receptor. Biophys J. 2016;111: 1396–1408. doi: 10.1016/j.bpj.2016.08.035 27705763

19. Dascal N. Signalling via the G protein-activated K+ channels. Cell Signal. 1997;9: 551–573. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9429760 doi: 10.1016/s0898-6568(97)00095-8 9429760

20. Sahlholm K, Marcellino D, Nilsson J, Fuxe K, Ãrhem P. Differential voltage-sensitivity of D2-like dopamine receptors. Biochem Biophys Res Commun. 2008;374: 496–501. Available: http://www.sciencedirect.com/science/article/pii/S0006291X08013879 doi: 10.1016/j.bbrc.2008.07.052 18652803


Článek vyšel v časopise

PLOS One


2019 Číslo 10
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#